Silwal-Pandit L, Stålberg SM, Johansson HJ, Mermelekas G, Lothe IMB, Skrede ML, Dalsgaard AM, Nebdal DJH, Helland Å, Lingjærde OC, Labori KJ, Skålhegg BS, Lehtiö J, Kure EH (2022) Proteome Analysis of Pancreatic Tumors Implicates Extracellular Matrix in Patient Outcome Cancer Res Commun, 2 (6), 434-446 DOI 10.1158/2767-9764.CRC-21-0100, PubMed 36923555 Røssevold AH, Andresen NK, Bjerre CA, Gilje B, Jakobsen EH, Raj SX, Falk RS, Russnes HG, Jahr T, Mathiesen RR, Lømo J, Garred Ø, Chauhan SK, Lereim RR, Dunn C, Naume B, Kyte JA (2022) Atezolizumab plus anthracycline-based chemotherapy in metastatic triple-negative breast cancer: the randomized, double-blind phase 2b ALICE trial Nat Med, 28 (12), 2573-2583 DOI 10.1038/s41591-022-02126-1, PubMed 36482103 Castro-Mondragon JA, Aure MR, Lingjærde OC, Langerød A, Martens JWM, Børresen-Dale AL, Kristensen VN, Mathelier A (2022) Cis-regulatory mutations associate with transcriptional and post-transcriptional deregulation of gene regulatory programs in cancers Nucleic Acids Res, 50 (21), 12131-12148 DOI 10.1093/nar/gkac1143, PubMed 36477895 More publications